期刊文献+

灵芝三萜合成关键元件GLCYP450及其还原酶GLNADPH的基因克隆及共表达载体构建 被引量:3

Construction of the coexpression vector containing key element GLCYP450 involved in Ganoderma triterpene biosynthesis and its reductase gene GLNADPH
原文传递
导出
摘要 细胞色素P450是灵芝三萜生物合成途径中的关键元件,其催化反应过程中需要有NADPH/NADH为其传递电子。本课题组根据已获得的赤芝(Ganoderma lucidum(Leyss.Ex Fr.)Karst.)基因组数据中的CYP450和NADPH转录本序列,利用RT-PCR方法获得灵芝CYP450(GLCYP450)和NADPH(GLNADPH)基因的全长cDNA序列,并在序列两端引入相应的限制性内切酶位点,通过酶切及连接反应,将GLCYP450和GLNADPH重组到酵母表达载体pESC-URA中,成功构建了酵母表达载体质粒pESC-GLNADPH-GLCYP450,为通过合成生物学手段研究灵芝三萜生物合成奠定基础。 Cytochrome P450 (CYP450) is a key element in the Ganoderma triterpenoid biosynthetic pathway. The catalytic reaction process for CYP450 requires NADPH / NADH for electron transfer. After searching the genome dataset of Ganoderma lucidum, the unique sequence encoding CYP450 and NADPH were discovered, separately. The open reading frames of GLCYP450 and GLNADPH were cloned separately using RT-PCR strategy from G. lucidum. The appropriate restriction enzyme cutting sites were introduced at the 5' and 3' ends of gene sequence. The genes of GLCYP450 and GLNADPH were recombined into the yeast expression vector pESC-URA, leading to the formation of the yeast expression plasmid pESC-GLNADPH-GLCYP450. This study provides a foundation for researching Ganoderma triterpene biosynthesis using the approach of synthetic biology.
出处 《药学学报》 CAS CSCD 北大核心 2013年第2期206-210,共5页 Acta Pharmaceutica Sinica
基金 国家自然科学基金重点项目(81130069) 国家科技支撑计划项目(2012BAI29B01) 教育部"长江学者与创新团队发展计划"项目(IRT1150)
关键词 灵芝 三萜生物合成 CYP450 NADPH Ganoderma lucidum triterpenoid biosynthesis CYP450 NADPH
  • 相关文献

同被引文献33

  • 1张保龙,倪万潮,张天真,郭旺珍,徐英俊,姚姝.花粉管通道法转基因抗虫棉外源基因的整合方式[J].江苏农业学报,2004,20(3):144-148. 被引量:6
  • 2郭丽琼,林俊芳,熊盛,陈守才.抗冷冻蛋白基因遗传转化草菇的研究[J].微生物学报,2005,45(1):39-43. 被引量:34
  • 3韩军丽,李振秋,刘本叶,王红,李国凤,叶和春.植物萜类代谢工程[J].生物工程学报,2007,23(4):561-569. 被引量:28
  • 4Campos Ziegenbein F, Hanssen H P, Konig W A. Secondary metabolites from Ganoderma lucidum and Spongiporus leucomallellus. Phytochemistry, 2006, 67(2): 202-211.
  • 5Liu Y W, Gao J L, Guan J, Qian Z M, Fang K, Li S E Evaluation of antiproliferative activities and action mechanisms of extracts from two species of Ganoderma on tumor cell lines. Journal of Agricultural and Food Chemistry, 2009, 57(8): 3087-3093.
  • 6Yue Q X, Cao Z W, Guan S H, Liu X H, Tao L, Wu W Y, Li Y X, Yang P Y, Liu X, Guo D A. Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network. Molecular & Cellular Proteomics, 2008, 7(5): 949-961.
  • 7Stanley G, Harvey K, Slivova V, Jiang J, Sliva D. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-betal from prostate cancer cells. Biochemical and Biophysical Research Communications, 2005, 330(1): 46-52.
  • 8Sliva D. Ganoderma lucidum in cancer research. Leukemia Research, 2006, 30(7): 767-768.
  • 9Muller C I, Kumagai T, O'Kelly J, Seeram N P, Heber D, Koeffler H P. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leukemia Research, 2006, 30(7): 841-848.
  • 10Xu J W, Zhao W, Zhong J J. Biotechnological production and application of ganoderic acids. Applied Microbiology and Biotechnolog, 2010, 87(2): 457-466.

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部